journal article·2016-12-14Open access

The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages

Sham Rampersaud, Justin Fang, Zengyan Wei, Kristina Fabijanic, Stefan Silver, Trisha Jaikaran, Yuleisy Ruiz, Murielle Houssou, Zhiwei Yin, Shengping Zheng, Ayako Hashimoto, Ayuko Hoshino, David Lyden, Shahana Mahajan, Hiroshi Matsui

Nano Letters· Volume 16· Issue 12

Abstract

Although a range of nanoparticles have been developed as drug delivery systems in cancer therapeutics, this approach faces several important challenges concerning nanocarrier circulation, clearance, and penetration. The impact of reducing nanoparticle size on penetration through leaky blood vessels around tumor microenvironments via enhanced permeability and retention (EPR) effect has been extensively examined. Recent research has also investigated the effect of nanoparticle shape on circulation and target binding affinity. However, how nanoparticle shape affects drug release and therapeutic efficacy has not been previously explored. Here, we compared the drug release and efficacy of iron oxide nanoparticles possessing either a cage shape (IO-NCage) or a solid spherical shape (IO-NSP). Riluzole cytotoxicity against metastatic cancer cells was enhanced 3-fold with IO-NCage. The shape of nanoparticles (or nanocages) affected the drug release point and cellular internalization, which in turn influenced drug efficacy. Our study provides evidence that the shape of iron oxide nanoparticles has a significant impact on drug release and efficacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Characterization and Applications of Magnetic Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Hunter College, City University of New York, 695 Park Avenue, New York, New York 10065, United States

Department of Chemistry, The Graduate Center of City University of New York, 365 Fifth Avenue, New York, New York 10016, United States

Department of Medical Laboratory Sciences, Hunter College, City University of New York, 425 East 25th Street, New York, New York 10010, United States

Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, New York 10021, United States

Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan

Funding

National Center for Advancing Translational Sciences · National Institute on Minority Health and Health Disparities · Children's Cancer and Blood Foundation · Champalimaud Foundation · Daedalus Fund for Innovation, Weill Cornell Medical College · Paduano Cancer Research Fund

References (50)

Show source-provided references
1. 10.1038/380561a010.1038/380561a0 ↗
2. 10.1517/1742524090357997110.1517/17425240903579971 ↗
3. 10.1093/jnci/djj07010.1093/jnci/djj070 ↗
4. 10.1016/S1053-4296(98)80042-810.1016/S1053-4296(98)80042-8 ↗
5. 10.1021/nn300652p10.1021/nn300652p ↗
6. 10.1038/nrc90310.1038/nrc903 ↗
7. Adams G. P. · Cancer Res. · 2001 · 61 · 4750
8. 10.1021/nn500299p10.1021/nn500299p ↗
9. 10.1021/acs.chemrev.5b0011210.1021/acs.chemrev.5b00112 ↗
10. 10.1016/j.bmc.2015.09.05010.1016/j.bmc.2015.09.050 ↗
11. 10.1016/j.jconrel.2007.03.02210.1016/j.jconrel.2007.03.022 ↗
12. 10.2217/nnm.13.19110.2217/nnm.13.191 ↗
13. 10.1038/nbt134010.1038/nbt1340 ↗
14. 10.1038/nbt.350610.1038/nbt.3506 ↗
15. 10.1016/j.jconrel.2010.07.11610.1016/j.jconrel.2010.07.116 ↗
16. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
17. 10.1517/17425247.2014.95056410.1517/17425247.2014.950564 ↗
18. 10.1021/mp900022m10.1021/mp900022m ↗
19. 10.1016/j.addr.2011.03.00510.1016/j.addr.2011.03.005 ↗
20. 10.1038/nrclinonc.2010.3810.1038/nrclinonc.2010.38 ↗
21. 10.1038/nrc318010.1038/nrc3180 ↗
22. 10.1021/ar200061q10.1021/ar200061q ↗
23. 10.1038/nmat284810.1038/nmat2848 ↗
24. 10.1126/science.109656610.1126/science.1096566 ↗
25. 10.1021/nl034097+10.1021/nl034097+ ↗
26. 10.1126/science.121282210.1126/science.1212822 ↗
27. 10.1021/nl100559y10.1021/nl100559y ↗
28. 10.1002/anie.20070067710.1002/anie.200700677 ↗
29. 10.1038/ncomms487010.1038/ncomms4870 ↗
30. 10.1002/jemt.2225110.1002/jemt.22251 ↗
31. 10.1126/science.123475110.1126/science.1234751 ↗
32. 10.1021/cm803201p10.1021/cm803201p ↗
33. 10.1039/c2cs15337h10.1039/c2cs15337h ↗
34. 10.3390/ijms14091750110.3390/ijms140917501 ↗
35. 10.1021/jp053421h10.1021/jp053421h ↗
36. 10.1016/0014-2999(93)90037-I10.1016/0014-2999(93)90037-I ↗
37. 10.7150/ijbs.647510.7150/ijbs.6475 ↗
38. 10.1002/wmts.2110.1002/wmts.21 ↗
39. 10.1007/s10549-011-1624-x10.1007/s10549-011-1624-x ↗
40. 10.1158/1078-0432.CCR-08-330310.1158/1078-0432.CCR-08-3303 ↗
41. Akamatsu K. · Anticancer Res. · 2009 · 29 · 2195
42. 10.1126/science.114724110.1126/science.1147241 ↗
43. 10.1021/nl902212q10.1021/nl902212q ↗
44. 10.1016/j.biomaterials.2005.05.05410.1016/j.biomaterials.2005.05.054 ↗
45. 10.1016/j.neuropharm.2016.02.01110.1016/j.neuropharm.2016.02.011 ↗
46. 10.1002/smll.20090052010.1002/smll.200900520 ↗
47. 10.1007/s00702-014-1182-610.1007/s00702-014-1182-6 ↗
48. 10.1007/s00418-009-0613-110.1007/s00418-009-0613-1 ↗
49. 10.1126/scitranslmed.aaf737410.1126/scitranslmed.aaf7374 ↗
50. 10.2217/nnm.09.6710.2217/nnm.09.67 ↗